Corvus Pharmaceuticals, Inc. — Director's Dealing 2017

Feb 10, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: Corvus Pharmaceuticals, Inc. (CRVS)
CIK: 0001626971
Period of Report: 2016-12-31

Reporting Person: LEA LEIV (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-08-25	Common Stock, $0.0001 par value	G	48000	$0.00	Disposed	151253	Indirect
2016-08-25	Common Stock, $0.0001 par value	G	2047	$0.00	Disposed	149206	Indirect

Footnotes

F1: A portion of these shares is subject to a right of repurchase held by the Issuer.

F2: These shares are held by Leiv Lea and Deborah Karlson, Trustees of the Karlson Lea Family Trust UTA dated February 11, 1998 (the "Karlson Lea Trust"). Mr. Lea has shared voting, investment and dispositive power over the shares held by the Karlson Lea Trust.